Literature DB >> 1327505

Endogenous tumor necrosis factor exerts its protective function intracellularly against the cytotoxicity of exogenous tumor necrosis factor.

T Okamoto1, N Watanabe, N Yamauchi, Y Tsuji, N Tsuji, Y Itoh, H Neda, Y Niitsu.   

Abstract

Based on the findings that expression of endogenous tumor necrosis factor (enTNF), which is not present in TNF-susceptible cells, was generally observed in TNF-resistant cells and that TNF gene transfection gives rise to TNF resistance, the assumption was made that enTNF may be a protective protein against the cytotoxicity of exogenous TNF. However, it remains unknown whether the protection by enTNF is exerted in an intracellular or extracellular (autocrine) manner. We therefore transfected a nonsecretory human TNF gene (pTNF delta pro) into highly TNF-sensitive mouse tumorigenic fibroblasts (L-M cells) and investigated their TNF susceptibility. The transfectants expressed enTNF which was not secreted into the medium and acquired an appreciable degree of resistance to exogenous TNF. A significant increase in the manganous superoxide dismutase level was also noted in the transfectants. These findings suggest that enTNF exerts its protective function intracellularly by inducing manganous superoxide dismutase production.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1327505

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Association of TNF-alpha and TNF-beta gene polymorphism with steroid receptor expression in breast cancer patients.

Authors:  Eskandar Kamali-Sarvestani; Behrouz Gharesi-Fard; Jamal Sarvari; Abd-Al-Rasoul Talei
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

2.  Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart.

Authors:  C Napoli; C Cicala; J L Wallace; F de Nigris; V Santagada; G Caliendo; F Franconi; L J Ignarro; G Cirino
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

Review 3.  Potential roles for tumour necrosis factor alpha during embryonic development.

Authors:  M A Wride; E J Sanders
Journal:  Anat Embryol (Berl)       Date:  1995-01

4.  Enhanced inhibition of experimental metastasis by the combination chemotherapy of Cu-Zn SOD and adriamycin.

Authors:  K Kogawa; H Muramatsu; M Tanaka; Y Nishihori; S Hagiwara; K Kuribayashi; K Nakamura; K Koike; S Sakamaki; Y Niitsu
Journal:  Clin Exp Metastasis       Date:  1999-05       Impact factor: 5.150

5.  Induction of tumour necrosis factor-alpha by single and repeated doses of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid.

Authors:  M Philpott; B C Baguley; L M Ching
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

6.  Effect of tumor necrosis factor-alpha and interferon-gamma on the growth of human prostate cancer cell lines.

Authors:  Y Nakajima; A DelliPizzi; C Mallouh; N R Ferreri
Journal:  Urol Res       Date:  1995

7.  Reversal of tumor necrosis factor resistance in tumor cells by adriamycin via suppression of intracellular resistance factors.

Authors:  N Watanabe; T Okamoto; N Tsuji; H Sasaki; S Akiyama; D Kobayashi; T Sato; N Yamauchi; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  1995-04

8.  Induction of synthesis of heat shock protein 72 in tumor necrosis factor gene-transduced cells.

Authors:  N Watanabe; S Akiyama; N Tsuji; H Sasaki; N Yamauchi; T Okamoto; D Kobayashi; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  1994-10

9.  Enhanced antitumor effect of recombinant human tumor necrosis factor in combination with recombinant human granulocyte colony-stimulating factor in BALB/c mice.

Authors:  M Maeda; N Watanabe; N Tsuji; Y Tsuji; T Okamoto; H Sasaki; S Akiyama; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  1993-08

10.  Enhancement of blood stasis and vascular permeability in Meth-A tumors by administration of hyperthermia in combination with tumor necrosis factor.

Authors:  H Umeno; N Watanabe; N Yamauchi; N Tsuji; T Okamoto; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  1994-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.